Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh
Thursday, October 24, 2013
Conference for Healthcare Transparency and Patient Advocacy, November 1, 2013 in Lexington KY
Labels:
510(k),
AdvaMed,
Daniel Saman,
FDA,
Healthwatch USA,
Helen Haskell,
implant device,
Joycelyn Elders,
Lisa McGiffert,
Martha Deed,
Marvin Feit,
patient harm,
PCORI,
product warranty,
Steve Kraman
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment